Wideblue customer CRiL start clinical trials at Addenbrookes hospital with new NTC1 product

15 February 2016

Cambridge Respiratory Innovations Ltd have received approval to start clinical trials of the new NTC1 product designed and built by Wideblue. Approval was given for the trials by the Cambridge University Hospitals NHS Foundation Trust for “clinical evaluation of the CRIL N-Tidal C data-collector capnometer to collect breathing records in patients with COPD”. Patients with COPD will be recruited for the trial starting in February and given a N Tidal C device to record their capnometry / CO2 breathing records over a few weeks. The trials are due to be completed by the 18th April 2016.